(Q48733192)

15 February 2018

title

CIP2A is a predictor of poor prognosis in colon cancer (English)

1 reference

15 February 2018

author name string

Hao-Wei Teng

1

1 reference

15 February 2018

Shung-Haur Yang

2

1 reference

15 February 2018

Jen-Kou Lin

3

1 reference

15 February 2018

Wei-Shone Chen

4

1 reference

15 February 2018

Tzu-Chen Lin

5

1 reference

15 February 2018

Jeng-Kai Jiang

6

1 reference

15 February 2018

Chueh-Chuan Yen

7

1 reference

15 February 2018

Anna Fen-Yau Li

8

1 reference

15 February 2018

Paul Chih-Hsueh Chen

9

1 reference

15 February 2018

Yuan-Tzu Lan

10

1 reference

15 February 2018

Chun-Chi Lin

11

1 reference

15 February 2018

Yen-Ning Hsu

12

1 reference

15 February 2018

Hsei-Wei Wang

13

1 reference

15 February 2018

Kuen-Feng Chen

14

1 reference

15 February 2018

publication date

11 February 2012

1 reference

15 February 2018

Journal of Gastrointestinal Surgery

published in

1 reference

15 February 2018

volume

16

1 reference

15 February 2018

issue

5

1 reference

15 February 2018

page(s)

1037-1047

1 reference

15 February 2018

Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

Single-cell multiplex gene detection and sequencing with microfluidically generated agarose emulsions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

A systematic review of FOLFOXIRI chemotherapy for the first-line treatment of metastatic colorectal cancer: improved efficacy at the cost of increased toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

Mechanisms of MYC stabilization in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

CIP2A inhibits PP2A in human malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

CIP2A expression is increased in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

CIP2A is associated with human breast cancer aggressivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

CIP2A is Overexpressed in Non-Small Cell Lung Cancer and Correlates with Poor Prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

KIAA1524: A novel MLL translocation partner in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

MYC-dependent regulation and prognostic role of CIP2A in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

Prognostic role of CIP2A expression in serous ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

Increase in CIP2A expression is associated with doxorubicin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

The MAPK signalling pathways and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

Regulation of Raf-1 activation and signalling by dephosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

Prognostic factors for neck pain in general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-012-1828-3

State disparities in colorectal cancer mortality patterns in the United States

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22328001

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Protein phosphatase 2A regulatory subunits and cancer.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22328001

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

CIP2A is overexpressed in gastric cancer and its depletion leads to impaired clonogenicity, senescence, or differentiation of tumor cells

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22328001

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S11605-012-1828-3

1 reference

15 February 2018

1 reference

15 February 2018